Published in Infect Immun on March 01, 1993
Diarrheagenic Escherichia coli. Clin Microbiol Rev (1998) 30.09
Prevalence of the "high-pathogenicity island" of Yersinia species among Escherichia coli strains that are pathogenic to humans. Infect Immun (1998) 3.17
Development of PCR for screening of enteroaggregative Escherichia coli. J Clin Microbiol (1995) 2.66
Phylogenetic analysis of enteroaggregative and diffusely adherent Escherichia coli. Infect Immun (1999) 2.51
Aggregative adherence fimbria II, a second fimbrial antigen mediating aggregative adherence in enteroaggregative Escherichia coli. Infect Immun (1997) 2.50
Evolution of the chaperone/usher assembly pathway: fimbrial classification goes Greek. Microbiol Mol Biol Rev (2007) 2.44
AggR, a transcriptional activator of aggregative adherence fimbria I expression in enteroaggregative Escherichia coli. J Bacteriol (1994) 2.37
New adhesin of enteroaggregative Escherichia coli related to the Afa/Dr/AAF family. Infect Immun (2008) 1.91
Identification and characterization of a gene cluster mediating enteroaggregative Escherichia coli aggregative adherence fimbria I biogenesis. J Bacteriol (1994) 1.62
Multiplex PCR for detection of three plasmid-borne genes of enteroaggregative Escherichia coli strains. J Clin Microbiol (2003) 1.55
The presence of the pAA plasmid in the German O104:H4 Shiga toxin type 2a (Stx2a)-producing enteroaggregative Escherichia coli strain promotes the translocation of Stx2a across an epithelial cell monolayer. J Infect Dis (2014) 1.54
Genomic characterization of enteroaggregative Escherichia coli from children in Mali. J Infect Dis (2011) 1.39
Organization of biogenesis genes for aggregative adherence fimbria II defines a virulence gene cluster in enteroaggregative Escherichia coli. J Bacteriol (1999) 1.34
A Serratia marcescens OxyR homolog mediates surface attachment and biofilm formation. J Bacteriol (2007) 1.27
Specific detection of enteroaggregative hemorrhagic Escherichia coli O104:H4 strains by use of the CRISPR locus as a target for a diagnostic real-time PCR. J Clin Microbiol (2012) 1.26
The major pilin subunit of the AAF/II fimbriae from enteroaggregative Escherichia coli mediates binding to extracellular matrix proteins. Infect Immun (2008) 1.18
Presence of enterohemorrhagic Escherichia coli ST678/O104:H4 in France prior to 2011. Appl Environ Microbiol (2011) 1.14
Virulence characteristics and molecular epidemiology of enteroaggregative Escherichia coli isolates from hospitalized diarrheal patients in Kolkata, India. J Clin Microbiol (2004) 1.12
Virulence markers of enteroaggregative Escherichia coli isolated from children and adults with diarrhea in Brasília, Brazil. J Clin Microbiol (2003) 1.11
Prevention and self-treatment of traveler's diarrhea. Clin Microbiol Rev (2006) 1.05
Enteroaggregative Escherichia coli: An Emerging Enteric Food Borne Pathogen. Interdiscip Perspect Infect Dis (2010) 1.04
Characterization of an invasive phenotype associated with enteroaggregative Escherichia coli. Infect Immun (1995) 1.04
Molecular cloning and characterization of the afa-7 and afa-8 gene clusters encoding afimbrial adhesins in Escherichia coli strains associated with diarrhea or septicemia in calves. Infect Immun (1999) 1.00
Enteroadherent Escherichia coli and diarrhea in children: a prospective case-control study. J Clin Microbiol (1996) 0.97
Antibodies raised against the outer membrane protein interrupt adherence of enteroaggregative Escherichia coli. Infect Immun (1995) 0.92
Structural insight into host recognition by aggregative adherence fimbriae of enteroaggregative Escherichia coli. PLoS Pathog (2014) 0.90
Repression of the inner membrane lipoprotein NlpA by Rns in enterotoxigenic Escherichia coli. J Bacteriol (2006) 0.88
Characterization of a novel hemagglutinin of diarrhea-associated Escherichia coli that has characteristics of diffusely adhering E. coli and enteroaggregative E. coli. Infect Immun (1996) 0.87
Antibiotic-resistant cell-detaching Escherichia coli strains from Nigerian children. J Clin Microbiol (2002) 0.86
Identification of cell surface-exposed proteins involved in the fimbria-mediated adherence of enteroaggregative Escherichia coli to intestinal cells. Infect Immun (2014) 0.85
Escherichia coli O104 in Feedlot Cattle Feces: Prevalence, Isolation and Characterization. PLoS One (2016) 0.85
Heat-resistant agglutinin 1 is an accessory enteroaggregative Escherichia coli colonization factor. J Bacteriol (2009) 0.84
Shiga toxin 2a and Enteroaggregative Escherichia coli--a deadly combination. Gut Microbes (2015) 0.81
Crystallization and initial crystallographic analysis of AafA: the major adhesive subunit of the enteroaggregative Escherichia coli AAF/II pilus. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.81
Crystal structure and analysis of HdaB: The enteroaggregative Escherichia coli AAF/IV pilus tip protein. Protein Sci (2016) 0.77
Surveillance of Diarrheagenic Escherichia coli Strains Isolated from Diarrhea Cases from Children, Adults and Elderly at Northwest of Mexico. Front Microbiol (2016) 0.75
Improved broad-host-range plasmids for DNA cloning in gram-negative bacteria. Gene (1988) 18.10
Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells. Pediatr Infect Dis J (1987) 7.15
Enteroaggregative Escherichia coli associated with persistent diarrhea in a cohort of rural children in India. J Infect Dis (1989) 4.52
Association of Escherichia coli HEp-2 adherence patterns with type and duration of diarrhoea. Lancet (1991) 4.52
Coli surface antigens 1 and 3 of colonization factor antigen II-positive enterotoxigenic Escherichia coli: morphology, purification, and immune responses in humans. Infect Immun (1984) 3.63
Aggregative adherence fimbriae I of enteroaggregative Escherichia coli mediate adherence to HEp-2 cells and hemagglutination of human erythrocytes. Infect Immun (1992) 3.30
Codon usage tabulated from the GenBank genetic sequence data. Nucleic Acids Res (1991) 3.01
A plasmid-encoded regulatory gene, rns, required for expression of the CS1 and CS2 adhesins of enterotoxigenic Escherichia coli. Proc Natl Acad Sci U S A (1989) 2.62
Type 1 fimbriae mutants of Escherichia coli K12: characterization of recognized afimbriate strains and construction of new fim deletion mutants. Mol Microbiol (1991) 2.47
Comparison of two assay methods for patterns of adherence to HEp-2 cells of Escherichia coli from patients with diarrhea. J Clin Microbiol (1990) 2.43
Enteroaggregative Escherichia coli elaborate a heat-stable enterotoxin demonstrable in an in vitro rabbit intestinal model. J Clin Invest (1991) 2.35
Enteroaggregative Escherichia coli and Salmonella associated with nondysenteric persistent diarrhea. Pediatr Infect Dis J (1989) 2.09
The positive regulator CfaD overcomes the repression mediated by histone-like protein H-NS (H1) in the CFA/I fimbrial operon of Escherichia coli. EMBO J (1992) 1.96
Characteristics of adherence of enteroaggregative Escherichia coli to human and animal mucosa. Infect Immun (1991) 1.86
A rns-like regulatory gene for colonization factor antigen I (CFA/I) that controls expression of CFA/I pilin. Infect Immun (1990) 1.37
Genetics of adhesive fimbriae of intestinal Escherichia coli. Curr Top Microbiol Immunol (1990) 1.23
Shuttle cloning vectors for the marine bacterium Vibrio parahaemolyticus. J Bacteriol (1984) 1.18
Association of rns homologs with colonization factor antigens in clinical Escherichia coli isolates. Infect Immun (1990) 1.14
Positive regulation of colonization factor antigen I (CFA/I) production by enterotoxigenic Escherichia coli producing the colonization factors CS5, CS6, CS7, CS17, PCFO9, PCFO159:H4 and PCFO166. J Gen Microbiol (1991) 1.04
Vibrio cholerae HlyA hemolysin is processed by proteolysis. Infect Immun (1990) 0.99
The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) (1977) 9.53
Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med (1994) 5.19
A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med (1998) 4.81
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Radioimmunoassay of human serum thyrotrophin. Br Med J (1971) 4.59
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun (1988) 4.44
A sensitive and specific DNA probe to identify enteroaggregative Escherichia coli, a recently discovered diarrheal pathogen. J Infect Dis (1990) 4.43
Thyrotrophin-releasing hormone as a thyroid-function test. Lancet (1971) 4.34
Detection of Shigella in feces using DNA amplification. J Infect Dis (1990) 3.61
Aggregative adherence fimbriae I of enteroaggregative Escherichia coli mediate adherence to HEp-2 cells and hemagglutination of human erythrocytes. Infect Immun (1992) 3.30
Grades of hypothyroidism. Br Med J (1973) 3.30
Vitiligo, thyroid disease and autoimmunity. Br J Dermatol (1968) 3.18
Heterogeneity of enteroaggregative Escherichia coli virulence demonstrated in volunteers. J Infect Dis (1995) 3.14
The thyrotrophin-releasing hormone test in diseases of the pituitary and hypothalamus. Lancet (1972) 3.10
Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region. JAMA (1986) 3.05
Thyroid-stimulating immunoglobulins in Graves' disease. Lancet (1974) 2.84
Major surface antigen gene of a human malaria parasite cloned and expressed in bacteria. Nature (1984) 2.74
Circulating sensitised lymphocytes in Graves' disease. Observations on its pathogenesis. Lancet (1970) 2.73
Conducting clinical research in the new NHS: the model of cancer. United Kingdom Coordinating Committee on Cancer Research. BMJ (1994) 2.70
Hopping hotspots: global shifts in marine biodiversity. Science (2008) 2.68
Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet (1974) 2.65
Multi-gene amplification: simultaneous detection of three virulence genes in diarrhoeal stool. Mol Microbiol (1989) 2.65
Carbimazole and the autoimmune response in Graves' disease. N Engl J Med (1980) 2.62
Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs. Lancet (1975) 2.57
Aggregative adherence fimbria II, a second fimbrial antigen mediating aggregative adherence in enteroaggregative Escherichia coli. Infect Immun (1997) 2.50
Bromocriptine therapy in acromegaly. Lancet (1975) 2.42
AggR, a transcriptional activator of aggregative adherence fimbria I expression in enteroaggregative Escherichia coli. J Bacteriol (1994) 2.37
Cyclosporin improves Graves' ophthalmopathy. Lancet (1983) 2.32
Treatment of hypothyroidism: a reappraisal of thyroxine therapy. Br Med J (1973) 2.30
An outbreak of foodborne illness caused by Escherichia coli O39:NM, an agent not fitting into the existing scheme for classifying diarrheogenic E. coli. J Infect Dis (1997) 2.10
Antigens of the erythrocytes stages of the human malaria parasite Plasmodium falciparum detected by monoclonal antibodies. Mol Biochem Parasitol (1983) 2.00
Natural history of autoimmune thyroiditis. Br Med J (Clin Res Ed) (1981) 1.99
Correlation of elastase production by some strains of Aspergillus fumigatus with ability to cause pulmonary invasive aspergillosis in mice. Infect Immun (1984) 1.97
Clinical pathology testing recommendations for nonclinical toxicity and safety studies. AACC-DACC/ASVCP Joint Task Force. Toxicol Pathol (1992) 1.94
Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ (1992) 1.86
Letter: Complication of proximal gastric vagotomy. Br Med J (1974) 1.82
Trial of strategy for reducing the use of laboratory tests. Br Med J (Clin Res Ed) (1986) 1.82
Thyroid-stimulating hormone response to synthetic thyrotrophin releasing hormone in man. Br Med J (1970) 1.79
Effusions into body cavities in hypothyroidism. Lancet (1975) 1.77
Serological evidence for simultaneous occurrences of Lyme disease and babesiosis. J Infect Dis (1985) 1.76
Serum-thyrotropin levels after subtotal thyroidectomy for Graves' disease. Lancet (1971) 1.73
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71
Simple method of assessing splenic function in coeliac disease. Clin Sci (Lond) (1981) 1.70
Prediction of outcome in Graves' disease after carbimazole treatment. Q J Med (1986) 1.68
Comparative analyses of phenotypic and genotypic methods for detection of enterotoxigenic Escherichia coli toxins and colonization factors. J Clin Microbiol (2007) 1.68
Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly. Lancet (1973) 1.68
Interplay between mycoplasmas and host target cells. Microb Pathog (1995) 1.67
Luteinizing hormone and follicle stimulating hormone-releasing hormone test in patients with hypothalamic-pituitary-gonadal dysfunction. Br Med J (1973) 1.66
Effects of bromocriptine on pituitary tumour size. Br Med J (1979) 1.64
Interaction between secretion of the gonadotrophins, prolactin, growth hormone, thyrotrophin and corticosteroids in man: the effects of LH FSH-RH, TRH and hypoglycaemia alone and in combination. Clin Endocrinol (Oxf) (1973) 1.60
Meningococcal disease in Wales: clinical features, outcome and public health management. J Infect (1992) 1.60
Recommendations on the management of the asymptomatic patient with valvular heart disease. Eur Heart J (2002) 1.59
A systematic approach to erectile dysfunction in the cardiovascular patient: a Consensus Statement--update 2002. Int J Clin Pract (2002) 1.58
Treatment of hyperthyroidism by radioactive iodine. Summary of a UK national survey prepared for the Royal College of Physicians Committee on Endocrinology and Diabetes. J R Coll Physicians Lond (1992) 1.56
A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression. Vaccine (2011) 1.53
Thyroid-autoantibody synthesis by Hashimoto thyroid lymphocytes. Lancet (1979) 1.52
Ribosomal RNA sequences of Sarcocystis muris, Theileria annulata and Crypthecodinium cohnii reveal evolutionary relationships among apicomplexans, dinoflagellates, and ciliates. Mol Biochem Parasitol (1991) 1.51
A systematic approach to erectile dysfunction in the cardiovascular patient: a consensus statement. Int J Clin Pract (1999) 1.51
Confirming the drugs administered during anaesthesia: a feasibility study in the pilot National Health Service sites, UK. Br J Anaesth (2010) 1.50
Myopathy in acromegaly. Lancet (1970) 1.50
Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin Endocrinol (Oxf) (1977) 1.49
Smoking cessation: a consensus statement with special reference to primary care. Int J Clin Pract (2001) 1.48
The immunoassay of thyroid-stimulating hormone and its clinical applications. Clin Endocrinol (Oxf) (1972) 1.47
Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf) (1980) 1.46
Pathogenicity and convalescent excretion of Campylobacter in rural Egyptian children. Am J Epidemiol (2001) 1.45
DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus. Virology (1998) 1.42
Production and partial characterization of an elastolytic protease of Vibrio vulnificus. Infect Immun (1985) 1.42
Hypothyroidism. Br Med J (1972) 1.41
Thyroid antibodies are produced by thyroid-derived lymphocytes. Clin Exp Immunol (1982) 1.39
Characterization of putative virulence genes on the related RepFIB plasmids harbored by Cronobacter spp. Appl Environ Microbiol (2011) 1.39
Use of plaque assays to study thyroglobulin autoantibody synthesis by human peripheral blood lymphocytes. Scand J Immunol (1981) 1.39
Catheter ablation of the atrioventricular node using radiofrequency energy. Aust N Z J Med (1994) 1.39
Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. Pediatrics (2001) 1.38
Processing, polymorphism, and biological significance of P190, a major surface antigen of the erythrocytic forms of Plasmodium falciparum. Mol Biochem Parasitol (1984) 1.37
History of dermatology in Northern Ireland. Br J Dermatol (1970) 1.36
Characterization of myosin light chains from histochemically identified fibres of rabbit psoas muscle. FEBS Lett (1975) 1.35
Phenotypic diversity of enterotoxigenic Escherichia coli strains from a community-based study of pediatric diarrhea in periurban Egypt. J Clin Microbiol (1999) 1.35
IS1414, an Escherichia coli insertion sequence with a heat-stable enterotoxin gene embedded in a transposase-like gene. Infect Immun (2000) 1.34
The effect of calcium ions on the binomial statistic parameters which control acetylcholine release at synapses in striated muscle. J Physiol (1975) 1.33
Risk factors, inpatient care, and outcomes of pneumonia after ischemic stroke. Neurology (2011) 1.33
Evidence for immunological cross-reaction between sporozoites and blood stages of a human malaria parasite. Nature (1984) 1.33
High-dose melphalan with autologous bone marrow transplantation for multiple myeloma. Blood (1986) 1.32
Further observations on the effect of synthetic thyrotropin-releasing hormone in man. Br Med J (1971) 1.32
Enzyme-linked immunoassay of monoclonal and serum microsomal autoantibodies. Clin Chim Acta (1984) 1.31
Identification of Shigella flexneri subserotype 1c in rural Egypt. J Clin Microbiol (1999) 1.30
Splenic size and function in adult coeliac disease. Br J Radiol (1980) 1.29
Guidelines for prevention of thromboembolic events in valvular heart disease. Ad Hoc Committee of the Working Group on Valvular Heart Disease, European Society of Cardiology. J Heart Valve Dis (1993) 1.29
Prediction of relapse in hyperthyroid Graves' disease. Lancet (1980) 1.27
Effect of Pseudomonas aeruginosa rhamnolipids on mucociliary transport and ciliary beating. J Appl Physiol (1985) (1992) 1.27
Hearing loss due to mumps. Arch Dis Child (1987) 1.27
Measurement of thyrotropin receptor antibodies. Methods Enzymol (1981) 1.26
Ophthalmic Graves' disease. Diagnosis and pathogenesis. Lancet (1970) 1.26
Thyrotrophin response to thyrotrophin-releasing hormone in ophthalmic Graves' disease: correlation with other aspects of thyroid function, thyroid suppressibility and activity of eye signs. Clin Endocrinol (Oxf) (1973) 1.25
Growth hormone release inhibiting hormone in acromegaly. Br Med J (1974) 1.24
Proteoglycans in dentinogenesis. Crit Rev Oral Biol Med (2001) 1.24
Methimazole inhibits thyroid autoantibody production by an action on accessory cells. Clin Immunol Immunopathol (1983) 1.23
Direct inhibition of gastric acid and pepsin secretion by growth-hormone release-inhibiting hormone in cats. Lancet (1975) 1.23
Epidemiology of rotavirus diarrhea in Egyptian children and implications for disease control. Am J Epidemiol (1999) 1.22
Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology. Eur Heart J (1995) 1.21